While no differences were noted in sex, age at diagnosis, duration from diagnosis to adalimumab initiation, or duration of adalimumab use, individuals with temporomandibular (TMJ) joint involvement were less likely to achieve inactive disease status (p= 0
While no differences were noted in sex, age at diagnosis, duration from diagnosis to adalimumab initiation, or duration of adalimumab use, individuals with temporomandibular (TMJ) joint involvement were less likely to achieve inactive disease status (p= 0.038). weeks (p= 0.023) and temporomandibular joint (TMJ) involvement (p= 0.038) identified those less likely to achieve inactive disease. […]
Recent Comments